Fosun Pharma Allocates 725,100 A-Share Options to Employees

Stock News08-28 19:00

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has announced a new round of equity incentives, granting a total of 725,100 A-share options to 100 eligible recipients.

According to the company's official announcement released on August 28, 2026, the board of directors resolved to award these options under the 2025 A-Share Option Plan on the same day. The options correspond to 725,100 A-shares of the company, representing approximately 0.0272% of the total issued shares as of the announcement date.

Under the terms of the 2025 A-Share Option Plan, the exercise price for these reserved options has been set at RMB 27.93 per share.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1184432934?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-28 19:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184432934","market":"other","top_or_hot":-1,"title":"Fosun Pharma Allocates 725,100 A-Share Options to Employees","media":"Stock News","content":"<p><b>Shanghai Fosun Pharmaceutical (Group) Co., Ltd.</b> (<b>02196</b>) has announced a new round of equity incentives, granting a total of 725,100 A-share options to 100 eligible recipients.<br><br>According to the company's official announcement released on August 28, 2026, the board of directors resolved to award these options under the 2025 A-Share Option Plan on the same day. The options correspond to 725,100 A-shares of the company, representing approximately 0.0272% of the total issued shares as of the announcement date.<br><br>Under the terms of the 2025 A-Share Option Plan, the exercise price for these reserved options has been set at RMB 27.93 per share.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fosun Pharma Allocates 725,100 A-Share Options to Employees</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFosun Pharma Allocates 725,100 A-Share Options to Employees\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-28 19:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Shanghai Fosun Pharmaceutical (Group) Co., Ltd.</b> (<b>02196</b>) has announced a new round of equity incentives, granting a total of 725,100 A-share options to 100 eligible recipients.<br><br>According to the company's official announcement released on August 28, 2026, the board of directors resolved to award these options under the 2025 A-Share Option Plan on the same day. The options correspond to 725,100 A-shares of the company, representing approximately 0.0272% of the total issued shares as of the announcement date.<br><br>Under the terms of the 2025 A-Share Option Plan, the exercise price for these reserved options has been set at RMB 27.93 per share.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02846","symbol_name":"安硕沪深三百","start_time":0,"source_url":"","article_id":"1184432934","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184432934","pubTimestamp":1787914813,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has announced a new round of equity incentives, granting a total of 725,100 A-share options to 100 eligible recipients.According to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"82846":"安硕沪深三百—R","83130":"恒生沪深三百-R","83188":"华夏沪深三百—R","159982":"中证500","399300":"沪深300","600196":"复星医药","02846":"安硕沪深三百","BK1515":"抗疫概念","BK1147":"投资银行业与经纪业","BK0196":"行业龙头","02196":"复星医药","BK0239":"医药制造","BK0096":"民营医院","03130":"恒生沪深三百","BK0183":"MSCI概念","07233":"南方两倍做多沪深300","BK0188":"融资融券","BK0012":"证金概念","02827":"标智沪深300","BK0187":"一线龙头","BK0028":"国家队","BK1191":"制药","BK1593":"医美概念股","BK0175":"白马股","BK0060":"抗癌","03188":"华夏沪深三百"},"translate_title":"复星医药向员工分配725,100份A股期权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"82846":1,"83130":1,"83188":1,"159982":1,"399300":1,"600196":1,"03130":1,"03188":1,"02846":1,"02196":1,"02827":1,"07233":1},"content_text":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has announced a new round of equity incentives, granting a total of 725,100 A-share options to 100 eligible recipients.According to the company's official announcement released on August 28, 2026, the board of directors resolved to award these options under the 2025 A-Share Option Plan on the same day. The options correspond to 725,100 A-shares of the company, representing approximately 0.0272% of the total issued shares as of the announcement date.Under the terms of the 2025 A-Share Option Plan, the exercise price for these reserved options has been set at RMB 27.93 per share.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1184432934","isCrawlerRequest":true}